What are you looking for? Search Common searches: Departments, Hospitalisation, Professionals, Outpatient clinics, Health advice, Accreditations, Diseases, Diagnostic tests, Treatments, The birth of a child, Emergency, Visiting patients, Fulltext search Tipus de contingut Services and units Professionals Pathologies Health advices Health and wellness Diagnostic tests Treatments News Activities Centers - Any - Search News Vall d’Hebron identifies a mechanism by which inflammation in the female genital tract increases the risk of new infections The study results show that the local presence of IL-1β promotes the development of myeloid cells with an immunosuppressive function. News Vall d’Hebron takes part in study demonstrating the first effective preventive treatment for migraine in children and adolescents The treatment with fremanezumab becomes the first approved therapy to demonstrate efficacy in children and adolescents, a key stage of life as it is one of the most disabling and concentrates the peak incidence of the disease. News Vall d’Hebron participates in an international consensus on cholangiocarcinoma The document provides a comprehensive evaluation of current knowledge on this type of cancer affecting the bile ducts. News El Legado de Pol boosts research into a rare pediatric leukemia with €20,761 for Vall d’Hebron The charitable initiative created in honor of Pol is supporting a research project aimed at identifying therapeutic targets to treat a rare type of leukemia. News D-Sight, a Vall d’Hebron spin-off, launches its first-in-human clinical trial of neuroprotective therapies for diabetic retinopathy and glaucoma The study will validate the safety of a novel topical ocular administration route for sitagliptin. News Seven Vall d’Hebron projects receive PERIS grants to boost strategic research on campus The grants will promote strategic projects in obesity, respiratory diseases, aortic pathology, metabolic fatty liver disease, precision oncology, early breast cancer diagnosis, and genomic risk stratification in cancer. News Vall d’Hebron takes part in a study showing the long-term benefits of ruxolitinib in paediatric graft-versus-host disease The REACH5 study confirms that the efficacy and safety results observed in previous studies are maintained after three years of follow-up. News Diesel particles increase the risk of severe cardiac arrhythmias, while antioxidant cerium oxide nanoparticles could protect the heart A study led by the Vall d'Hebron Research Institute (VHIR) demonstrates the causal role of air pollution in ventricular arrhythmias and identifies a possible therapeutic strategy based on antioxidants. News Vall d’Hebron receives 14 grants from the Spanish Association Against Cancer to boost research Campus projects secure more than €2.2 million and strengthen translational oncology research. Pathologies Age-related macular degeneration (AMD) AMD is a degenerative disease of the retina and is currently the leading cause of vision loss and blindness in older people in developed countries. Pagination Previous page ‹‹ Page 273 Next page ››